BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 22188861)

  • 1. Screening of Associated Factors for Erectile Dysfunction after Radical Prostatectomy and Construction of a Clinical Risk Assessment Model: A Retrospective Study.
    Mi Z; Liu J; Wang L; Luo Y; Yang K
    Arch Esp Urol; 2024 Jan; 77(1):92-97. PubMed ID: 38374018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence factors of erectile dysfunction in patients with localized prostate cancer after radical surgery].
    Wang SH; Shi XQ; Ma MF; Jin XX; Zhao XD; Zhou YL; Gu YF; Hu J; Dong N; Dong J; Xu S
    Zhonghua Nan Ke Xue; 2023 Dec; 29(12):992-999. PubMed ID: 38639951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence rate of prostate cancer in men treated for erectile dysfunction with phosphodiesterase type 5 inhibitors: retrospective analysis.
    Chavez AH; Scott Coffield K; Hasan Rajab M; Jo C
    Asian J Androl; 2013 Mar; 15(2):246-8. PubMed ID: 23353723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition.
    Tsilidis KK; Allen NE; Appleby PN; Rohrmann S; Nöthlings U; Arriola L; Gunter MJ; Chajes V; Rinaldi S; Romieu I; Murphy N; Riboli E; Tzoulaki I; Kaaks R; Lukanova A; Boeing H; Pischon T; Dahm CC; Overvad K; Quirós JR; Fonseca-Nunes A; Molina-Montes E; Gavrila Chervase D; Ardanaz E; Khaw KT; Wareham NJ; Roswall N; Tjønneland A; Lagiou P; Trichopoulos D; Trichopoulou A; Palli D; Pala V; Tumino R; Vineis P; Bueno-de-Mesquita HB; Malm J; Orho-Melander M; Johansson M; Stattin P; Travis RC; Key TJ
    Int J Cancer; 2015 Jan; 136(2):372-81. PubMed ID: 24862312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing postoperative sexual function after radical prostatectomy.
    Tutolo M; Briganti A; Suardi N; Gallina A; Abdollah F; Capitanio U; Bianchi M; Passoni N; Nini A; Fossati N; Rigatti P; Montorsi F
    Ther Adv Urol; 2012 Dec; 4(6):347-65. PubMed ID: 23205061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in prostate cancer incidence around sixty years: effects of age and metabolic diseases.
    Choi JB; Kim JH; Hong SH; Han KD; Ha US
    Cancer Med; 2018 Jun; 7(6):2736-2743. PubMed ID: 29696814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erectile function recovery at 12 months after radical prostatectomy for prostate cancer is not associated with overall survival.
    Takeda T; Benfante NE; Assel M; Mulhall JP; Oya M; Touijer KA
    Int J Urol; 2019 Sep; 26(9):934-935. PubMed ID: 31240770
    [No Abstract]   [Full Text] [Related]  

  • 8. Erectile dysfunction and the risk of prostate cancer.
    Lin WY; Chang YH; Lin CL; Kao CH; Wu HC
    Oncotarget; 2017 Aug; 8(32):52690-52698. PubMed ID: 28881762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and the risk of biochemical recurrence in patients with treated localized prostate cancer: a meta-analysis.
    Hua Q; Zhu Y; Liu H; Ye X
    Int Urol Nephrol; 2016 Sep; 48(9):1437-43. PubMed ID: 27170341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and management of post prostatectomy erectile dysfunction.
    Salonia A; Castagna G; Capogrosso P; Castiglione F; Briganti A; Montorsi F
    Transl Androl Urol; 2015 Aug; 4(4):421-37. PubMed ID: 26816841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between preoperative erectile dysfunction and prostate cancer features--an analysis from the Duke Prostate Center Database.
    Kimura M; Bañez LL; Gerber L; Qi J; Tsivian M; Freedland SJ; Satoh T; Polascik TJ; Baba S; Moul JW
    J Sex Med; 2012 Apr; 9(4):1174-81. PubMed ID: 22188861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of Baseline Erectile Function in Men Following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated Measures.
    Sridhar AN; Cathcart PJ; Yap T; Hines J; Nathan S; Briggs TP; Kelly JD; Minhas S
    J Sex Med; 2016 Mar; 13(3):435-43. PubMed ID: 26944466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy.
    Pierorazio PM; Lin BM; Mullins JK; Hyndman ME; Schaeffer EM; Han M; Partin AW; Pavlovich CP
    Urol Oncol; 2013 Jul; 31(5):589-94. PubMed ID: 21664838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting erectile function recovery after bilateral nerve sparing radical prostatectomy: a proposal of a novel preoperative risk stratification.
    Briganti A; Gallina A; Suardi N; Capitanio U; Tutolo M; Bianchi M; Passoni N; Salonia A; Colombo R; Di Girolamo V; Guazzoni G; Rigatti P; Montorsi F
    J Sex Med; 2010 Jul; 7(7):2521-31. PubMed ID: 20487236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone as a predictor of pathological stage in clinically localized prostate cancer.
    Isom-Batz G; Bianco FJ; Kattan MW; Mulhall JP; Lilja H; Eastham JA
    J Urol; 2005 Jun; 173(6):1935-7. PubMed ID: 15879785
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.